Genuit Share Discussion Threads

[pippit] 09/11/2005 15:53

Trust me the T trade at 11.75p was a sell.

[rambutan2] 09/11/2005 14:39

benn, there's usually a reasonable newsflow on their website, just not on rns.

[ben gunn] 09/11/2005 11:20

Damn, got within 1/4p of the limit bid that would have doubled my holding.
Will have to wait and see again. Keep the news flowing chaps, the company does not seem to know what newsflow is.

[cyberian] 09/11/2005 11:06

Another 100,000 delayed T Trade done at 11.75p showing as a sell but in fact a BUY....so, apart from a small 25,000 sell at 12.25p all buys. Feeling quite comfortable for a medium term hold, at least.

[cyberian] 09/11/2005 10:00

Big rise this morning on little volume initially...something afoot? The 100,000 showing as a sell is in fact the main catalyst for the share price increase as looking at the time of the trade it is a BUY! So a slightly delayed trade is starting to suggest better things maybe ahead, or at least some are seeing the value as reported in the last 2 posts.

[rambutan2] 06/11/2005 14:14

kd, what makes you think cmr or sphere will ipo within six months?

the mkt still sees gen as a risky share and so it will suffer when folks turn risk averse. if they prove that the consulting side can churn out profit then im sure that sentiment will change over time. however, this is very much an under researched/unknown share and on a v small mkt cap. but as you suggest, it does possess the ability to very much surprise on the upside. i wouldnt bet on when that will happen though.

[waldron] 13/10/2005 08:35

Generics to receive shares in Nanoscience after Toumaz purchase

LONDON (AFX) - Generics Group AG said it will receive a stake of 3.59 pct in
Nanoscience Inc after its purchase yesterday of Toumaz Technology Ltd for 17.7
mln stg.
Nanoscience also announced a placing to raise approximately 7.1 mln stg at
15 pence per share.
Generics together with other funds managed by its subsidiary Generics Asset
Management Limited completed its initial investment in Toumaz in September 2002
and has been actively engaged in the development of Toumaz.

[e-mail]
slm/

[adejuk] 06/10/2005 18:28

ben, wait till the sphere ipo next summer. you'll need wings to catch it!

[ben gunn] 20/9/2005 19:43

Not exactly up, up, and away is it?
(To misquote Maureen Lipman)

[rambutan2] 20/9/2005 10:42

and the cause of adejuk's excitement...

Sphere Medical awarded Frost & Sullivan's 2005 Technology Innovation Award

The Generics Group AG is pleased to announce that one of its portfolio
companies, Sphere Medical Holding Limited, the developer of next generation
critical care monitoring systems, has been awarded the Frost & Sullivan 2005
Technology Innovation Award in the field of Point-of-Care ('PoC') Technologies.
This award has been granted in recognition of Sphere Medical's design and
development of an innovative microanalyser system that could profoundly impact
the PoC sector.

Frost & Sullivan's Technology Innovation Award is bestowed upon a company that
has carried out new research which has resulted in innovation that has, or is,
expected to bring significant contributions to the industry in terms of
adoption, change, and competitive posture.

Dr. Stuart Hendry, CEO of Sphere Medical, commented:

'It is very pleasing to see that a leading independent industry commentator such as Frost and Sullivan has recognised the potential of Sphere Medical's products amongst significant competition.'

Martin Frost, Generics' Managing Director added:

'This is the fourth prestigious award for innovation that Generics and its
portfolio companies have received over a 12 month period. Sphere is addressing a very large end-market, in which the quality of innovation is a critical
differentiator.'

The Generics Group holds an equity interest of 10.3% (after exercise of employee share options) in Sphere Medical.

[adejuk] 20/9/2005 07:09

sphere could be worth a billion if five years.
10% of that alone compared with the current gen mkt cap?

[adejuk] 20/9/2005 07:07

and who's that coming up fast on the rails?
don't say you weren't forewarned.
this will be like winning the lottery in a year.

[rambutan2] 16/9/2005 11:05

??????????!!!!!!!!!!!??????

Excitation and processing circuitry is provided for energising the excitation winding and for processing the sensor signals to determine a value incücative of the relative position between the first and second relatively movable members

hmmmmm

[maxwellsdemon] 16/9/2005 07:26

New patent application published yesterday 15 September 2005 :

(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT)

(11) WO 2005/085763
(13) A2


(21) PCT/GB2005/000775

(22) 01 March 2005 (01.03.2005)

(25) English
(26) English

(30) 0404585.2 01 March 2004
(01.03.2004) GB
0420735.3 17 September 2004
(17.09.2004) GB
(43) 15 September 2005 (15.09.2005)
(51)7 G01D 5/00
(54) POSITION SENSOR
(71) SCIENTIFIC GENERICS LIMITED [GB/GB]; Harston Mill, Harston, Cambridge CB2 5GG (GB).
(72)
(75) ZHITOMIRSKIY, Victor, Evgenievich [RU/GB]; Scientific Generics Limited, Harston Mill, Harston, Cambridge CB2 5GG (GB).
(74) BERESFORD & CO; 16 High Holborn, London WV1V 6BX (GB).
(81) AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
(84) ARIPO patent (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian patent (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), European patent (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR), OAPI patent (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG, BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)

For information on time limits for entry into the national phase please click here
Published
-- without international search report and to be republished upon receipt of that report


(57) A position encoder is provided for indicating the relative position between first and second relatively move members. One of the members carries a magnetic field generator which generates a magnetic field whose magnitude and direction vary with position. In a preferred embodiment, the other member carries an excitation winding, one or more sensor windings and a film of magnetisabe material. The arrangement is such that the positionally varying magnetic field interacts with the film to change the mutual coupling between the excitation winding and the or each sensor winding. Excitation and processing circuitry is provided for energising the excitation winding and for processing the sensor signals to determine a value incücative of the relative position between the first and second relatively movable members

[rambutan2] 16/9/2005 00:34

for the record...

On the 2nd September 2005 Martin Forster, Company Secretary and Director,
informed the Company that on 1st September 2005 he purchased an additional
100,000 shares of CHF 0.10 each in Generics at 12 pence per share. His total holding of CHF 0.10 shares now stands at 799 400 shares.

[adejuk] 15/9/2005 19:03

nice retrace. a year from now this price will look silly. sphere is a ten bagger technology. will save hospitals a bloody fortune in monitoring costs and make us lots safer when we are in the awful places. won't stop mrsa unfort. - the remedy for that is lots of shares in hceg!

[rambutan2] 09/9/2005 10:29

sphere not, i am!

[adejuk] 09/9/2005 09:57

said months ago that these are grossly undervalued but it seems the world is beginning to wake up to that.
watch out for sphere!

[ariane] 30/8/2005 08:19

Interim Results

RNS Number:5593Q
Generics Group AG
30 August 2005


30 August 2005

THE GENERICS GROUP AG ('GENERICS')

INTERIM RESULTS 2005

Generics, a leading integrated technology consulting, development and investment
organisation, today announces its results for the six months to 30 June 2005.

Highlights:

* Turnover increased by 28% to #10.7m (H1 2004: #8.3m)
* Consulting and IP exploitation activities reported operating profit of
#0.3m (H1 2004 loss of #0.1m) while increasing fee income by 34%
* Operating loss for the Group of #0.9m (H1 2004 loss of #2.1m) after
expensed costs of spinouts of #0.6m
* Portfolio BVCA valuation of #12.5m (Q1 2005: #11.9m)
* Cash balance of #3.6m (Q4 2004: #5.1m) before proceeds of #1.05m from
the disposal of Imerge Ltd
* Generics' spinout CMR Fuel Cells Ltd received the 2005 Carbon Trust
award as Innovator of the year and in addition was a winner of the
Individual and Small Business of the Year category
* Successful completions of #4m financing by Sphere Medical Holding Ltd,
originally Generics' medical device joint venture with Siemens, and #2.3m
financing by CMR Fuel Cells Ltd
* Launch of SGAI Tech Ltd, Scientific Generics' Hong Kong based joint
venture
* Adjusted losses per share of 0.5 pence (2004 loss of 1.0 pence)
* Net assets per share of 8.7p per share (H1 2004: 9.4p) before taking
into account the BVCA portfolio valuation uplift equivalent to 3.5p per
share (H1 2004: 3.0p)

On 11 August 2005 Generics announced that it had completed the sale of its
shareholding in Imerge Limited. The consideration included a cash payment of
#1.05m, and future incentive payments dependent upon performance. The BVCA
valuation for Generics' share of Imerge at Q1 2005 was #1.3m.

Johan Bjorklund, Generics' Chairman, commented:

"I am pleased with both the development of the group during the first six months
and the progress in the consulting and IP exploitation activities in particular.
Our core technology development and consulting activity grew significantly,
increasing fee income by 34% year-on-year whilst achieving a good and increasing
profitability. SGAI Tech, our Hong Kong based joint venture, is performing ahead
of forecast, adding new clients to its initial customer, Hornby plc. Income from
licensing and royalty activities will improve with the next AutosheathTM
milestone payment of $0.5m expected in the second half. While Q3 is likely to
see a moderate seasonal reduction in revenue and sales run-rate, the order book
and sales processes are now strong enough to sustain the ongoing growth in the
technology consulting and IP business.

Within our venturing activity during the first half we have received industry
accolades for our spinout companies, CMR Fuel Cells Ltd and Sphere Medical
Holding Ltd, both of which have been successfully financed in the year to date.
Various funding, IPO and disposal opportunities continue to be developed across
the portfolio. The prospects for CMR and Sphere, in particular, are strong."

Enquiries:
The Generics Group AG (44) 1223 875200
Martin Frost www.genericsgroup.com
Simon Davey

[maxwellsdemon] 30/8/2005 07:49

Results out:

[elgordo] 28/8/2005 15:26

CMR Fuel Cells is expanding -

[elgordo] 19/8/2005 17:51

I particularly noticed the phrase "another step in consolidating
our portfolio". Does this mean that Generics is backing away from the early stage investment business, or simply that they are tidying up those investments they currently have as part of the on-going management of the portfolio?

Whilst posting, I'll just mention that the interims were on on 24 August last year, so we should probably be expecting this year's in the next few weeks.

[rambutan2] 19/8/2005 14:23

for the record...
11/08/05:
The Generics Group AG ('Generics') announces that it has completed the sale of
its shareholding in Imerge Limited. The initial cash consideration received by
Generics was #1,050,290, excluding amounts held in escrow and future incentive
payments depending on performance.

The BVCA valuation of Imerge for our share at Q1 2005 was #1.3m.

Martin Frost, Managing Director, Generics Group commented:

"The disposal of our stake in Imerge Limited is another step in consolidating
our portfolio. Although the initial price received is slightly below the latest
BVCA valuation, we do anticipate further consideration through future payments
over the next 2-3 years."

[maxwellsdemon] 19/8/2005 14:15

New patent application just published yesterday

(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT)

(11) WO 2005/075995
(13) A1


(21) PCT/GB2005/000367

(22) 03 February 2005 (03.02.2005)

(25) English
(26) English

(30) 0402326.3 03 February 2004
(03.02.2004) GB
0402324.8 03 February 2004
(03.02.2004) GB
0402325.5 03 February 2004
(03.02.2004) GB
0402327.1 03 February 2004
(03.02.2004) GB
0402323.0 03 February 2004
(03.02.2004) GB
0404924.3 04 March 2004
(04.03.2004) GB
0405313.8 09 March 2004
(09.03.2004) GB
0405312.0 09 March 2004
(09.03.2004) GB
0408535.3 16 April 2004
(16.04.2004) GB
(43) 18 August 2005 (18.08.2005)
(51)7 G01N 33/543, A61B 5/00
(54) SENSOR
(71) SPHERE MEDICAL LTD [GB/GB]; Harston Mill, Harston, Cambridge CB2 5GG (GB).
(72)
(75) LAITENBERGER, Peter, G. [DE/GB]; c/o Sphere Medical Ltd, Harston Mill, Harston, Cambridge CB2 5GG (GB). HENDRY, Stuart, P. [GB/GB]; c/o Sphere Medical Ltd, Harston Mill, Harston, Cambridge CB2 5GG (GB). TROUGHTON, Gavin, L. [GB/GB]; c/o Sphere Medical Ltd, Harston Mill, Harston, Cambridge CB2 5GG (GB).
(74) ELKINGTON AND FIFE LLP; Prospect House, 8 Pembroke Road, Sevenoaks, Kent TN13 1XR (GB).
(81) AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
(84) ARIPO patent (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian patent (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), European patent (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR), OAPI patent (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG, BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)

For information on time limits for entry into the national phase please click here
Published
-- with international search report
-- before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments


(57) This invention relates to a sensor suitable for detecting the presence of one or more analytes. The sensor comprises a substrate; a confinement structure disposed on the substrate, wherein the confinement structure comprises at least a first limiting structure defining a first interior space; a transducer proximal to the first interior space; and a first synthetic polymer capable of selectively binding a first analyte, within the confinement structure. The confinement structure may have a second or further limiting structure defining a second or further interior space containing the first or preceding interior space. The sensor may also have additional confinement structures containing different materials for detecting additional analytes or taking reference measurements